eudragit rs has been researched along with HIV Coinfection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cazorla-Luna, R; Martín-Illana, A; Notario-Pérez, F; Rubio, J; Ruiz-Caro, R; Tamayo, A; Veiga, MD | 1 |
Bedoya, LM; Cazorla-Luna, R; Martín-Illana, A; Notario-Pérez, F; Rubio, J; Ruiz-Caro, R; Tamayo, A; Veiga, MD | 1 |
2 other study(ies) available for eudragit rs and HIV Coinfection
Article | Year |
---|---|
Optimization of tenofovir release from mucoadhesive vaginal tablets by polymer combination to prevent sexual transmission of HIV.
Topics: Acrylic Resins; Administration, Intravaginal; Animals; Chitosan; Delayed-Action Preparations; Female; Galactans; HIV Infections; Humans; Hypromellose Derivatives; Mannans; Mucous Membrane; Plant Gums; Reverse Transcriptase Inhibitors; Tablets; Tenofovir | 2018 |
Influence of Chitosan Swelling Behaviour on Controlled Release of Tenofovir from Mucoadhesive Vaginal Systems for Prevention of Sexual Transmission of HIV.
Topics: Acrylic Resins; Adhesives; Animals; Cattle; Cell Line; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Female; Galactans; HIV Infections; Humans; Hypromellose Derivatives; Mannans; Mucous Membrane; Plant Gums; Polymers; Sexually Transmitted Diseases; Tablets; Tenofovir; Vagina | 2017 |